NephroPlus, Asia’s largest dialysis services provider and the fifth largest globally, will open its Initial Public Offering (IPO) for subscription on December 10. The issue will close on December 12.

The IPO price band has been set at Rs 438 to Rs 460 per equity share, with a discount of Rs 41 per share offered to eligible employees. The offering comprises a fresh issue of shares worth Rs 353.4 crore and an Offer for Sale (OFS) of 1,12,53,102 equity shares by existing shareholders, a company statement said on Thursday.

The company plans to use Rs 129.1 crore from the fresh issue for capital expenditure to open new dialysis clinics across India, while Rs 136 crore will be allocated toward prepayment or repayment of borrowings.

Founded in 2009 and headquartered in Hyderabad, NephroPlus operates India’s largest organized dialysis network, spanning 288 cities across 21 States and 4 union Territories. Internationally, it runs 51 clinics across the Philippines, Uzbekistan and Nepal, bringing its total global footprint to 519 clinics. Its 165-bed dialysis centre in Tashkent is the largest such facility in the world.

NephroPlus offers a wide range of services including haemodialysis, home haemodialysis, hemodiafiltration, holiday dialysis, dialysis on call and dialysis on wheels.

The Indian dialysis services market, valued at USD 818 million in FY 2024, is projected to grow to USD 1,979 million by 2029, indicating strong long-term potential for the sector, the statement added.